Diseases & Disorders
(G97Z)
990 on File
ACADEMY CLINICAL LABORATORY PHYSICIANS AND SCIENTISTS
Financial strength (30%)
86/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$82K
Total Revenue
$88K
Total Expenses
$1.7M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
90.5%
Fundraising Efficiency
N/A
Operating Reserve
230.58x
Liability-to-Asset
0.0%
Revenue Diversification
49.2%
Compared with Peers
FY 2024
Compared with 1,426 similar organizations
(United States, Diseases & Disorders, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
90.5% | 80.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.5% | 10.1% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
230.6 mo | 23.3 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
49.2% | 99.5% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
10.6% | -0.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
25.5% | 0.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.2% | 8.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $82K | $88K | $1.7M | 90.5% | 0 |
| 2023 | $74K | $70K | $1.4M | 79.8% | 0 |
| 2022 | $67K | $99K | $1.3M | 89.5% | 0 |
| 2021 | $85K | $46K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.